This page is part of the Genetic Reporting Implementation Guide (v3.0.0-ballot: STU 3 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions
<DiagnosticReport xmlns="http://hl7.org/fhir">
<id value="PGxGenomicReportEMERGE"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomic-report"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><h2><span title="Codes: {http://loinc.org 51969-4}, {http://example.org/hgsc.bcm.edu/lab-test-codes/ emerge-seq-ngs-pnl}">Genetic analysis report</span> (<span title="Codes: {http://terminology.hl7.org/CodeSystem/v2-0074 GE}">Genetics</span>) </h2><table class="grid"><tr><td>Subject</td><td><b>Adam B. Everyman </b> male, DoB: 1951-01-20 ( Medical Record Number: m123 (use: USUAL))</td></tr><tr><td>When For</td><td>2020-01-01 00:00:00-0500</td></tr><tr><td>Reported</td><td>2020-01-01 00:00:00-0500</td></tr></table><p><b>Report Details</b></p><table class="grid"><tr><td><b>Code</b></td><td><b>Value</b></td><td><b>Note</b></td><td><b>When For</b></td></tr><tr><td><a href="Observation-OverallInterpExample2.html"><span title="Codes: {http://loinc.org 51968-6}">Discrete variation analysis overall interpretation</span></a></td><td><span title="Codes: {http://loinc.org LA6576-8}">Positive</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-TxImp01.html"><span title="Codes: {http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}">Therapeutic Implication</span></a></td><td/><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-TxImp02.html"><span title="Codes: {http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}">Therapeutic Implication</span></a></td><td/><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-TxImp03.html"><span title="Codes: {http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}">Therapeutic Implication</span></a></td><td/><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-TxImp04.html"><span title="Codes: {http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}">Therapeutic Implication</span></a></td><td/><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-TxImp05.html"><span title="Codes: {http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}">Therapeutic Implication</span></a></td><td/><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-TxImp06.html"><span title="Codes: {http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs therapeutic-implication}">Therapeutic Implication</span></a></td><td/><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-geno-1001.html"><span title="Codes: {http://loinc.org 84413-4}">Genotype display name</span></a></td><td><span title="Codes: {http://www.ncbi.nlm.nih.gov/clinvar 638797}">CYP2C19*2/*2</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-geno-1003.html"><span title="Codes: {http://loinc.org 84413-4}">Genotype display name</span></a></td><td><span title="Codes: ">VKORC1 rs9923231 C/T</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-geno-1002.html"><span title="Codes: {http://loinc.org 84413-4}">Genotype display name</span></a></td><td><span title="Codes: ">CYP2C9*1/*1</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1011.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td/><td>2020-01-01</td></tr><tr><td><a href="Observation-Pgx-var-1012.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1013.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1014.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1015.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1016.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1017.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1018.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td/><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1019.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td>This variant was confirmed with SANGER sequencing</td><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1020.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td>This variant was confirmed with SANGER sequencing</td><td>2019-04-01</td></tr><tr><td><a href="Observation-Pgx-var-1021.html"><span title="Codes: {http://loinc.org 69548-6}">Genetic variant assessment</span></a></td><td><span title="Codes: {http://loinc.org LA9633-4}">Present</span></td><td>This variant was confirmed with SANGER sequencing</td><td>2019-04-01</td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomic-study-reference">
<valueReference>🔗
<reference value="Procedure/PGXGenomicStudy"/>
</valueReference>
</extension>
<extension
url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action">
<valueReference>🔗
<reference value="Task/PGxRecEx01"/>
<display value="No clopidogrel"/>
</valueReference>
</extension>
<extension
url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action">
<valueReference>🔗
<reference value="Task/PGxRecEx02"/>
<display value="No voriconazole"/>
</valueReference>
</extension>
<extension
url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action">
<valueReference>🔗
<reference value="Task/PGxRecEx03"/>
<display value="50% citalopram"/>
</valueReference>
</extension>
<extension
url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action">
<valueReference>🔗
<reference value="Task/PGxRecEx04"/>
<display value="50% escitalopram"/>
</valueReference>
</extension>
<extension
url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action">
<valueReference>🔗
<reference value="Task/PGxRecEx04"/>
<display value="50% amitriptyline"/>
</valueReference>
</extension>
<extension
url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomic-report-note">
<valueAnnotation>
<extension
url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/annotation-code">
<valueCodeableConcept>
<coding>
<system
value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/coded-annotation-types-cs"/>
<code value="test-disclaimer"/>
</coding>
</valueCodeableConcept>
</extension>
<text
value="This test was developed and its performance determined by this laboratory. It has not been cleared or approved by U.S. Food and Drug Administration.
Since FDA Approval is not required for clinical use of this test, this laboratory has established and validated the test's accuracy and precision,
pursuant to the requirement of CLIA '88. This laboratory is licensed and/or accredited under CLIA and CAP (CAP# xxxxxxx / CLIA# xxxxxxxxxx)."/>
</valueAnnotation>
</extension>
<basedOn>🔗
<reference value="ServiceRequest/eMERGEServiceRequest"/>
</basedOn>
<status value="final"/>
<category>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
<code value="GE"/>
</coding>
</category>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="51969-4"/>
</coding>
<coding>
<system value="http://example.org/hgsc.bcm.edu/lab-test-codes/"/>
<code value="emerge-seq-ngs-pnl"/>
</coding>
</code>
<subject>🔗
<reference value="Patient/CGPatientExample01"/>
</subject>
<effectiveDateTime value="2020-01-01T00:00:00-05:00"/>
<issued value="2020-01-01T00:00:00-05:00"/>
<performer>🔗
<reference value="Organization/ExampleOrg"/>
</performer>
<result>🔗
<reference value="Observation/OverallInterpExample2"/>
<display value="gene-drug interactions found."/>
</result>
<result>🔗
<reference value="Observation/TxImp01"/>
<display value="clopidogrel, poor metabolizer"/>
</result>
<result>🔗
<reference value="Observation/TxImp02"/>
<display value="voriconazole, poor metabolizer"/>
</result>
<result>🔗
<reference value="Observation/TxImp03"/>
<display value="citalopram, poor metabolizer"/>
</result>
<result>🔗
<reference value="Observation/TxImp04"/>
<display value="escitalopram, poor metabolizer"/>
</result>
<result>🔗
<reference value="Observation/TxImp05"/>
<display value="amitriptyline, poor metabolizer"/>
</result>
<result>🔗
<reference value="Observation/TxImp06"/>
<display value="medium sensitivity to warfarin"/>
</result>
<result>🔗
<reference value="Observation/Pgx-geno-1001"/>
<display value="CYP2C19*2/*2"/>
</result>
<result>🔗
<reference value="Observation/Pgx-geno-1003"/>
<display value="VKORC1 rs9923231 C/T"/>
</result>
<result>🔗
<reference value="Observation/Pgx-geno-1002"/>
<display value="CYP2C9*1/*1"/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1011"/>
<display value="NC_000010.10(CYP2C19):g.96521657C="/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1012"/>
<display value="NC_000010.10(CYP2C19):g.96522463A="/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1013"/>
<display value="NC_000010.10(CYP2C19):g.96535173T="/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1014"/>
<display value="NC_000010.10(CYP2C19):g.96535210G="/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1015"/>
<display value="NC_000010.10(CYP2C19):g.96540410G>A"/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1016"/>
<display value="NC_000010.10(CYP2C19):g.96541616G="/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1017"/>
<display value="NC_000010.10(CYP2C19):g.96541756T="/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1018"/>
<display value="NC_000010.10(CYP2C19):g.96612495C="/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1019"/>
<display value="NC_000016.9(VKORC1):g.31096368C>T"/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1020"/>
<display value="NC_000010.10(CYP2C9):g.96702047C="/>
</result>
<result>🔗
<reference value="Observation/Pgx-var-1021"/>
<display value="NC_000010.10(CYP2C9):g.96741053A="/>
</result>
</DiagnosticReport>
IG © 2022+ HL7 International / Clinical Genomics. Package hl7.fhir.uv.genomics-reporting#3.0.0-ballot based on FHIR 4.0.1. Generated 2023-12-18
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change